Neoadjuvant intratumoral immunotherapy with cowpea mosaic virus induces local and systemic antitumor efficacy in canine mammary cancer patients
G Valdivia, D Alonso-Miguel, MD Perez-Alenza… - Cells, 2023 - mdpi.com
The lack of optimal models to evaluate novel agents is delaying the development of effective
immunotherapies against human breast cancer (BC). In this prospective open label study …
immunotherapies against human breast cancer (BC). In this prospective open label study …
Increased risk of ovarian and breast malignancies in women with polycystic ovary syndrome: a review article
H Chen, Q Jiang, Y Yin - Cellular and Molecular Biology, 2023 - cellmolbiol.org
Polycystic ovary syndrome (PCOS) is one of the common abnormalities in 5 to 8% of
reproductive-age women, which is associated with high levels of androgens and polycystic …
reproductive-age women, which is associated with high levels of androgens and polycystic …
A study of clinical and molecular characteristics in bilateral primary breast cancer
B Li, W Xu, J Cao, D Guo, Z Tao, J Jin, X Hu - Cancer Medicine, 2023 - Wiley Online Library
Background Bilateral primary breast cancer (BPBC) is a rare type of breast cancer. Studies
on the clinicopathologic and molecular characteristics of BPBC in a metastatic context are …
on the clinicopathologic and molecular characteristics of BPBC in a metastatic context are …
B cell lymphoma 6 promotes hepatocellular carcinoma progression by inhibiting tumor infiltrating CD4+T cell cytotoxicity through ESM1
J Li, J Feng, Z Li, Y Ni, L Liu, X Lei, Z Chai… - NPJ Precision …, 2024 - nature.com
Immunotherapy exhibited potential effects for advanced hepatocellular carcinoma,
unfortunately, the clinical benefits are often countered by cancer adaptive immune …
unfortunately, the clinical benefits are often countered by cancer adaptive immune …
Survival analysis for patients with metachronous contralateral breast cancer: Insights from a retrospective study
BK Park, J Schneider, YJ Suh - Oncology Letters, 2024 - spandidos-publications.com
Continued advances in the diagnosis and treatment of breast cancer (BC) have led to an
increase in the number of long-term BC survivors and an increase in the incidence of …
increase in the number of long-term BC survivors and an increase in the incidence of …
[HTML][HTML] Patient-derived organoid elucidates the identical clonal origin of bilateral breast cancer with diverse molecular subtypes
Z Han, L Yao, Y Fang, S Chen, R Lian, Y Yao… - Frontiers in …, 2024 - ncbi.nlm.nih.gov
Bilateral breast cancer (BBC), an infrequent breast cancer subtype, has primarily been
studied in terms of incidence, prognosis, and through comparative analysis of synchronous …
studied in terms of incidence, prognosis, and through comparative analysis of synchronous …
[PDF][PDF] Neoadjuvant Intratumoral Immunotherapy with Cowpea Mosaic Virus Induces Local and Systemic Antitumor Efficacy in Canine Mammary Cancer Patients. Cells …
G Valdivia, D Alonso-Miguel, MD Perez-Alenza… - 2023 - pdfs.semanticscholar.org
The lack of optimal models to evaluate novel agents is delaying the development of effective
immunotherapies against human breast cancer (BC). In this prospective open label study …
immunotherapies against human breast cancer (BC). In this prospective open label study …
[PDF][PDF] SYNCHRONOUS BILATERAL BREAST CANCER WITH DIFFERENT HER-2 EXPRESSION: A CASE REPORT
DAR Amelia, W Rajabto, A Kurniawan, C Sari… - researchgate.net
Background Synchronous bilateral breast cancers (SBBC) are rare and associated with
poorer survival than unilateral breast cancers (BC). Most of tumor pairs had similar …
poorer survival than unilateral breast cancers (BC). Most of tumor pairs had similar …